Capillaroscopic pattern in systemic sclerosis - an association with dynamics of processes of angio- and vasculogenesis

Microvascular Research

Volumn 80, Issue 3, 2010, Pages 534-539

  Lambova, Sevdalina N ^a   Müller Ladner, Ulf ^b  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Capillaroscopy; Systemic sclerosis; Vasculogenesis

Indexed keywords

ANGIOGENESIS INHIBITOR;

ANGIOGENESIS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CAPILLAROSCOPY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; ENDOTHELIUM CELL; HEMODYNAMICS; HUMAN; IN VITRO STUDY; MICROVASCULATURE; PRIORITY JOURNAL; REVIEW; SYSTEMIC SCLEROSIS;

ANIMALS; CAPILLARIES; ENDOTHELIAL CELLS; HUMANS; MICROCIRCULATION; MICROSCOPIC ANGIOSCOPY; NEOVASCULARIZATION, PHYSIOLOGIC; SCLERODERMA, SYSTEMIC; STEM CELLS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78249260310     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.07.005     Document Type: Review

References (46)

1. Allanore Y., et al. Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients. Ann. Rheum. Dis. 2007, 66:257-259.
2. Avouac J., et al. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann. Rheum. Dis. 2008, 67(10):1455-1460.
3. Avouac J., et al. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelal progenitor derived cells under hypoxic conditions. Arthritis Rheum. 2008, 58(11):3550-3561.
4. Bergman R., et al. The handheld dermatoscope as a nailfoiled capillaroscopic instrument. Arch. Dermatol. 2003, 139:1027-1030.
5. Bollinger A., Fagrell B. Clinical capillaroscopy - a guide to its use in clinical research and practice 1990, 1-123. Hogrefe & Huber Pub.
6. Caplice N.M., Doyle B. Vascular progenitor cells: origin and mechanisms of mobilization, differentiation, integration, and vasculogenesis. Stem Cells Dev. 2005, 14:122-139.
7. Cipriani P., et al. Impairment of endothelial cell differentiation from bone marrowderived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum. 2007, 56(6):1994-2004.
8. Cortes S., Cutolo M. Capillaroscopic patterns in rheumatic diseases. Acta Reum Port. 2007, 32:29-36.
9. Cutolo M., et al. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J. Rheumatol. 2000, 27:155-160.
10. Cutolo M., Pizzorni C., Sulli A. Capillaroscopy. Best Pract. Res. Clin. Rheumatol. 2005, 19(3):437-452.
11. Del Papa N., et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum. 2004, 50:1296-1304.
12. Del Papa N., et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum. 2006, 54(8):2605-2615.
13. Distler O., et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res. 2002, 4(6):R11.
14. Distler J.H.W., Gay S., Distler O. Angiogenesis and vasculogenesis in systemic sclerosis. Rheumatol. 2006, 45(Suppl 3):26-27.
15. Distler J.H.W., et al. EUSTAR statement and recommendations on endothelial precursor cells. Ann. Rheum. Dis. 2009, 68(2):163-168.
16. Dor Y., et al. Conditional switching of VEGF provides new insights into adult neovascularization and proangiogenic therapy. EMBO J. 2002, 21:1939-1947.
17. Ferri C., et al. Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin. Clin. Exp. Dermatol. 2007, 32:287-290.
18. Gill M., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2+AC133+endothelial precursor cells. Circ. Res. 2001, 88:167-174.
19. Giusti B., et al. The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. Arthritis Rheum. 2005, 52(11):3618-3628.
20. Gomer R.H. Circulating progenitor cells and scleroderma. Curr. Rheumatol. Rep. 2008, 10(3):183-188.
21. Guiducci S., et al. Mechanisms of vascular damage in SSc - implications for vascular treatment strategies. Rheumatology (Oxford) 2008, 47:v18-v20.
22. Herrick A.L., Clark S. Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis. Ann. Rheum. Dis. 1998, 57:70-78.
23. Heeschen C., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003, 102:1340-1346.
24. Huang P., et al. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diab. Care 2005, 28:2155-2160.
25. Hudson M., et al. Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin. Exp. Rheumatol. 2007, 25(5):754-757.
26. Hur J., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:288-293.
27. Ishigatsubo Y., et al. Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells. Mod. Rheumatol. 2010, 20(3):263-272.
28. Kuwana M., et al. Defective vasculogenesis in systemic sclerosis. Lancet 2004, 364:603-610.
29. Kuwana M., et al. Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis. Arthritis Rheum. 2006, 54(6):1946-1951.
30. Lambova S., Nikolova J.G., Kuzmanova S.I. Capillaroscopic pattern in systemic sclerosis and primary Raynaud's phenomenon. Scientific session of Union of scientists in Bulgaria-Plovdiv 2009, Xpp:3-6.
31. Le Roy E.C. et Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J. Rheumatol. 2001, 28:1573-1576.
32. Llevadot J., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J. Clin. Invest. 2001, 108:399-405.
33. Lonzetti L.S., et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum. 2001, 44(3):735-736.
34. Manetti M., et al. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J. Cell. Mol. Med. 2010, 14(6A):1241-1254.
35. Maricq H.R., et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum. 1980, 23(2):183-189.
36. Miniati I., et al. Autologous stem cell transplantation improves microcirculation in systemic sclerosis. Ann. Rheum. Dis. 2009, 68:94-98.
37. Mulligan-Kehoe M.J., et al. Antiangiogenic plasma activity in patients with systemic sclerosis. Arthritis Rheum. 2007, 56(10):3448-3458.
38. Mulligan-Kehoe M.J., Simons M. Vascular disease in scleroderma: angiogenesis and vascular repair. Rheum. Dis. Clin. North Am. 2008, 34:73-79.
39. Nagy Z., Czirjac L. Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud' disease. J Europ Acad Dermatol Venerol. 2004, 18:62-68.
40. Nevskaya T., et al. Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis. Rheumatology 2009, 48:61-64.
41. Peichev M., et al. Expression of VEGFR-2 and AC133 by circulating human CD341 cells identifies a population of functional endothelial precursors. Blood 2000, 95:952-958.
42. Shore A.C. Capillaroscopy and measurement of capillary pressure. Br. J. Clin. Pharmacol. 2000, 50(6):501-513.
43. Silver R.M., Medsger, Bolster M.B. Systemic Sclerosis and Scleroderma Variants: Clinical Aspects. Arthritis and allied conditions 2005, 1633-1680. Lippincot Williams&Wilkins, Philadelphia. 15th ed. W.J. Koopman (Ed.).
44. Sweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
45. Xiong W., Derk C.T. Treatment of systemic sclerosis: potential role for stem cell transplantation. Stem Cells and Cloning: Advances and Applications 2009, 2:1-9.
46. Zammaretti P., Zisch A.H. Adult "endothelial progenitor cells". Renewing vasculature. Int. J. Biochem. Cell Biol. 2005, 37:493-503.